The same researchers conducted another study with the same tagged anti-EGFR antibodies with 20 patients with HNC and demonstrated that in situ tumors were associated with higher fluorescent intensities than healthy tissue, regardless of age, sex, tumor site, or size [52]. The gene discussed is EGFR; the disease is neoplasm.